- Home
- CLFD vs TRDA Comparison
CLFD vs TRDA Comparison
Compare CLFD & TRDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLFD
- TRDA
- Stock Information
- Founded
- CLFD 1979
- TRDA 2016
- Country
- CLFD United States
- TRDA United States
- Employees
- CLFD N/A
- TRDA N/A
- Industry
- CLFD Telecommunications Equipment
- TRDA Biotechnology: Pharmaceutical Preparations
- Sector
- CLFD Utilities
- TRDA Health Care
- Exchange
- CLFD Nasdaq
- TRDA Nasdaq
- Market Cap
- CLFD 524.0M
- TRDA 609.7M
- IPO Year
- CLFD N/A
- TRDA 2021
- Fundamental
- Price
- CLFD $28.26
- TRDA $17.85
- Analyst Decision
- CLFD Strong Buy
- TRDA Strong Buy
- Analyst Count
- CLFD 3
- TRDA 3
- Target Price
- CLFD $46.67
- TRDA $23.33
- AVG Volume (30 Days)
- CLFD 154.3K
- TRDA 132.5K
- Earning Date
- CLFD 11-07-2024
- TRDA 11-05-2024
- Dividend Yield
- CLFD N/A
- TRDA N/A
- EPS Growth
- CLFD N/A
- TRDA N/A
- EPS
- CLFD N/A
- TRDA 1.55
- Revenue
- CLFD $166,705,000.00
- TRDA $215,232,000.00
- Revenue This Year
- CLFD $15.12
- TRDA $47.63
- Revenue Next Year
- CLFD N/A
- TRDA N/A
- P/E Ratio
- CLFD N/A
- TRDA $11.51
- Revenue Growth
- CLFD N/A
- TRDA 146.92
- 52 Week Low
- CLFD $24.78
- TRDA $10.75
- 52 Week High
- CLFD $44.83
- TRDA $20.49
- Technical
- Relative Strength Index (RSI)
- CLFD 22.53
- TRDA 48.42
- Support Level
- CLFD $33.06
- TRDA $19.28
- Resistance Level
- CLFD $38.51
- TRDA $20.49
- Average True Range (ATR)
- CLFD 1.65
- TRDA 0.92
- MACD
- CLFD -0.80
- TRDA -0.01
- Stochastic Oscillator
- CLFD 1.16
- TRDA 25.21
About CLFD Clearfield Inc.
Clearfield Inc mainly designs, manufactures, and distributes fiber protection, fiber management and fiber delivery solutions for communications networks. It provides a range of products including copper assemblies, cassettes, box enclosures, fiber connectors, frames, microduct, terminals, vaults, pedestal inserts, FieldSmart, WaveSmart, and CraftSmart. The company has a global presence with the majority of the revenue derived from the United States. The company has two reportable segments namely Clearfield segment and Nestor cables segment. The majority of revenue is derived from Clearfield segment.
About TRDA Entrada Therapeutics Inc.
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of patients by establishing a new class of medicines that engage intracellular targets that have long been considered inaccessible. The Company's Endosomal Escape Vehicle (EEV)-therapeutics are designed to enable the efficient delivery of a wide range of therapeutics into a variety of organs and tissues, resulting in an improved therapeutic index. Its pipeline includes solutions for Neuromuscular Disease, Beyond Neuromuscular, and Platform Expansion.